↓ Skip to main content

Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases

Overview of attention for article published in Frontiers in immunology, October 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases
Published in
Frontiers in immunology, October 2022
DOI 10.3389/fimmu.2022.1016927
Pubmed ID
Authors

Catherine E. Raptis, Christoph T. Berger, Adrian Ciurea, Diego O. Andrey, Christos Polysopoulos, Pierre Lescuyer, Tanja Maletic, Myriam Riek, Almut Scherer, Isabell von Loga, Judith Safford, Kim Lauper, Burkhard Möller, Nicolas Vuilleumier, Axel Finckh, Andrea Rubbert-Roth

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 12%
Student > Master 3 12%
Student > Ph. D. Student 3 12%
Student > Postgraduate 2 8%
Other 1 4%
Other 2 8%
Unknown 12 46%
Readers by discipline Count As %
Medicine and Dentistry 7 27%
Business, Management and Accounting 1 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Economics, Econometrics and Finance 1 4%
Engineering 1 4%
Other 0 0%
Unknown 15 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 November 2022.
All research outputs
#15,789,576
of 25,443,857 outputs
Outputs from Frontiers in immunology
#15,436
of 31,668 outputs
Outputs of similar age
#209,193
of 438,346 outputs
Outputs of similar age from Frontiers in immunology
#828
of 1,933 outputs
Altmetric has tracked 25,443,857 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,668 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,346 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 1,933 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.